The Johns Hopkins Center for AIDS Research (JHU CFAR)

CFAR的使命是催化、支持和维持创新研究的继续，以结束 艾滋病毒在美国和全球流行；我们的愿景是结束艾滋病从这里开始。在过去的9年中 多年来，CFAR重新唤起了调查人员的社区意识和联系 医学院、彭博公共卫生学院、护理学院和其他JHU分部；建立 开展跨学科协作的蓬勃发展的平台；参与新阶段和早期阶段 从事前沿研究活动的研究人员(ESI)；为以下项目提供急需的发展资源 开展试点研究；并为招聘或保留13名初级教员作出了贡献，特别是8名 代表人数不足的人口的成员。先导研究发展奖、小额赠款 已向217名应急计划和艾滋病毒新调查员提供了项目和补充品，所得资金为263美元 在随后的外部资金中有100万美元。自那以来，JHU撰写的艾滋病毒出版物增加了80% 2008年，共有1240个项目得到CFAR的支持。美国国立卫生研究院提供的所有艾滋病毒赠款中有40%现在是 授予Esis和从CFAR获得发展支持的新调查人员(相比之下，7% 当CFAR开始时)，整个艾滋病毒资助研究基数每年增加1900万美元。慷慨大方 机构联合资助支持巴尔的摩艾滋病毒合作实验室在 社区，涉及众多利益攸关方，包括巴尔的摩市卫生局和社区 组织。合作实验室还努力扩大未来艾滋病毒研究人员的渠道，通过 巴尔的摩艾滋病毒学者计划，明天的一代和明天的一代健康差距学者 重视来自代表性不足人群的受训人员的流水线计划。我们建立了大西洋中部 CFAR联盟(MACC)与哥伦比亚特区和宾夕法尼亚州CFARs共同支持艾滋病毒研究 在所有三个城市进行预防，并向代表人数不足的人口中的艾滋病人颁发MACC奖学金。 我们的具体目标是1)加强跨JHU和JHU的艾滋病毒/艾滋病研究的整合和生产力 与社区和世界各地的合作伙伴合作；2)为以下项目提供指导、支持和试点资金 下一代艾滋病毒/艾滋病研究人员，并增加来自团体的新调查人员的管道 在医学和卫生领域代表性不足；3)支持多学科艾滋病毒/艾滋病研究，提供 通过四个服务核心向调查人员提供关键服务；以及4)从 通过研究在巴尔的摩和圣彼得堡地区抗击当地的艾滋病毒流行 伙伴关系、培训、成果传播和加强社区干预。CFAR 有7个核心和2个科学工作组，提供服务并支持高优先级艾滋病毒的创新 研究。CFAR将继续对艾滋病毒/艾滋病研究产生激励和变革性的影响 JHU和我们很高兴提交这份续签申请。

The mission of the CFAR is to catalyze, support, and sustain the continuation of innovative research to end the HIV epidemic in the United States and globally; our vision is The End of AIDS Begins Here. For the past 9 years the CFAR has reinvigorated a sense of community and connectedness among investigators in the School of Medicine, Bloomberg School of Public Health, School of Nursing, and other JHU divisions; built thriving platforms through which interdisciplinary collaboration occurs; engaged new and early stage investigators (ESI) in cutting-edge research activities; provided vitally needed developmental resources for conducting pilot studies; and contributed to the recruitment or retention of 13 junior faculty members, notably 8 members of underrepresented populations. Developmental Awards for pilot studies, microgrants for small projects, and supplements have been provided to 217 ESI and investigators new to HIV, resulting in $263 million in subsequent extramural funding. JHU-authored publications on HIV have increased by 80% since 2008, with a total of 1240 supported by the CFAR. Forty percent of all HIV grants from the NIH are now awarded to ESIs and new investigators who received developmental support from this CFAR (compared to 7% when CFAR began), and the overall HIV funding research base has grown by $19 million per year. Generous institutional co-funding supports the Baltimore HIV Collaboratory to build stronger connections within the community, involving numerous stakeholders including the Baltimore City Health Department and community organizations. The Collaboratory is also worked expanding the pipeline of future HIV researchers through the Baltimore HIV Scholars Program, Generation Tomorrow and Generation Tomorrow Health Disparities Scholars pipeline programs emphasizing trainees from underrepresented populations. We established the Mid-Atlantic CFAR Consortium (MACC) with the District of Columbia and Penn CFARs that supports research on HIV prevention in all three cities and awards MACC Scholar Grants to ESIs from underrepresented populations. Our specific aims are 1) To enhance the integration and productivity of HIV/AIDS research across JHU and with partners in the community and around the world; 2) To provide mentoring, support, and pilot funding for the next generation of HIV/AIDS researchers, and to increase the pipeline of new investigators from groups underrepresented in medicine and health; 3) To support multidisciplinary HIV/AIDS research by providing critical services to investigators through four service cores; and 4) to mobilize and coordinate capacity from across JHU to combat the local HIV epidemic in the Baltimore and St. Petersburg areas through research partnerships, training, results dissemination, and strengthening of community-based interventions. The CFAR has 7 Cores and 2 Scientific Working Groups that provide services and support innovation in high-priority HIV research. The CFAR will continue to have a galvanizing and transformative impact on HIV/AIDS research at JHU and we are delighted to submit this renewal application.